Context-dependent modulation of alphabetagamma and alphabetadelta GABA A receptors by penicillin: implications for phasic and tonic inhibition.
Penicillin, an open-channel blocker of GABA(A) receptors, was recently reported to inhibit phasic, but not tonic, currents in hippocampal neurons. To distinguish between isoform-specific and context-dependent modulation as possible explanations for this selectivity, the effects of penicillin were evaluated on recombinant GABA(A) receptors expressed in HEK293T cells. When co-applied with saturating GABA, penicillin decreased peak amplitude, induced rebound, and prolonged deactivation of currents evoked from both synaptic and extrasynaptic receptor isoforms. However, penicillin had isoform-specific effects on the extent of desensitization, reflecting its ability to differentially modulate peak (non-equilibrium) and residual (near-equilibrium) currents. This suggested that the context of activation could determine the apparent sensitivity of a given receptor isoform to penicillin. To test this hypothesis, we explored the ability of penicillin to modulate synaptic and extrasynaptic isoform currents that were activated under more physiologically relevant conditions. Interestingly, while currents evoked from synaptic isoforms under phasic conditions (transient activation by a saturating concentration of GABA) were substantially inhibited by penicillin, currents evoked from extrasynaptic isoforms under tonic conditions (prolonged application by a sub-saturating concentration of GABA) were minimally affected. We therefore concluded that the reported inability of penicillin to modulate tonic currents could not simply be attributed to insensitivity of extrasynaptic receptors, but rather, reflected an inability to modulate these receptors in their native context of activation.
Feng
Hua-Jun
HJ
Department of Neurology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Botzolakis
Emmanuel J
EJ
Macdonald
Robert L
RL
D002461:Cell Line, Transformed; D006801:Humans; D015640:Ion Channel Gating / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D008564:Membrane Potentials / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D008954:Models, Biological; D018408:Patch-Clamp Techniques / Q000379:methods; D010406:Penicillins / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism; D021122:Protein Subunits; D011963:Receptors, GABA-A / Q000187:drug effects / Q000502:physiology*; D014162:Transfection; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D010406:Penicillins; D021122:Protein Subunits; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid; D011188:Potassium
J Neurochem. 2003 Dec;87(6):1444-55
14713300
Mol Pharmacol. 2004 Oct;66(4):988-1003
15247320
Br J Pharmacol. 1992 Nov;107(3):732-7
1335335
J Neurosci. 2004 Sep 29;24(39):8629-39
15456836
J Neurosci. 2007 Jul 11;27(28):7520-31
17626213
Adv Pharmacol. 2006;54:147-69
17175814
J Neurosci. 1994 Nov;14(11 Pt 2):7077-86
7525894
Mol Pharmacol. 1999 Jul;56(1):110-5
10385690
J Neurophysiol. 2003 Feb;89(2):871-83
12574465
J Neurosci. 2004 Sep 29;24(39):8454-8
15456818
J Physiol. 1977 Jan;264(1):89-124
190384
J Physiol. 1957 Aug 29;138(1):63-80
13463799
J Physiol. 2007 Aug 1;582(Pt 3):1163-78
17525114
Neuropharmacology. 1997 Jan;36(1):63-73
9144642
Nature. 1977 Jun 23;267(5613):720-1
195224
Trends Neurosci. 2004 May;27(5):262-9
15111008
Biophys J. 2005 Mar;88(3):1740-54
15626699
J Neurosci. 2006 Feb 8;26(6):1749-58
16467523
J Neurosci. 1998 Mar 1;18(5):1693-703
9464994
Br J Pharmacol. 1986 Jul;88(3):541-7
2427143
J Physiol. 2002 Oct 1;544(Pt 1):3-18
12356876
Trends Neurosci. 1996 Apr;19(4):139-43
8658597
Trends Neurosci. 1996 Mar;19(3):96-101
9054063
Br J Pharmacol. 2000 Jan;129(2):402-8
10694249
Brain Res. 2004 Dec 17;1029(2):207-16
15542076
J Neurophysiol. 2002 May;87(5):2624-8
11976398
Neuropharmacology. 2004 Dec;47(7):945-60
15555630
J Physiol. 1992 Jan;445:97-127
1323672
J Neurosci. 2002 May 15;22(10):RC223
12006605
J Physiol. 1978 May;278:207-35
671288
Brain Res. 1992 Nov 13;595(2):249-55
1281737
J Physiol. 2007 Nov 1;584(Pt 3):769-87
17884921
Neuroscience. 1994 Mar;59(2):259-73
7911981
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15230-5
17005728
Br J Pharmacol. 2002 Jan;135(2):427-32
11815378
Epilepsy Res. 1996 Nov;25(3):185-90
8956915
Epilepsy Res. 2000 Jan;38(1):33-44
10604604
J Physiol. 1999 Jan 1;514 ( Pt 1):27-45
9831714
J Neurophysiol. 2003 Apr;89(4):1929-40
12612040
Mol Pharmacol. 1996 Mar;49(3):494-504
8643089
Neurochem Res. 1994 Jan;19(1):1-4
8139755
Neuron. 1995 Jul;15(1):181-91
7542462
J Neurosci. 2002 Mar 1;22(5):1541-9
11880484
J Physiol. 2007 Feb 1;578(Pt 3):655-76
17124266
J Physiol. 2006 Apr 1;572(Pt 1):183-200
16455693
J Comp Neurol. 2002 Jan 28;443(1):43-55
11793346
J Physiol. 1978 Apr;277:153-76
306437
J Neurosci. 2003 Nov 19;23(33):10650-61
14627650
Mol Pharmacol. 2004 Dec;66(6):1517-24
15331770
Trends Neurosci. 2004 Sep;27(9):569-75
15331240
J Membr Biol. 1996 Nov;154(1):11-21
8881023
J Physiol. 1978 May;278:237-50
671293
Mol Pharmacol. 2006 Feb;69(2):564-75
16282519
Pharmacol Ther. 2004 Jun;102(3):195-221
15246246
Nat Neurosci. 2007 Jan;10(1):40-8
17159992
Eur J Pharmacol. 2004 Aug 2;496(1-3):23-32
15288571
Nat Neurosci. 1998 Nov;1(7):563-71
10196563
J Physiol. 1977 Jun;268(2):291-318
301570
Mol Pharmacol. 2003 Jan;63(1):2-8
12488530
J Physiol. 1979 Oct;295:139-70
42780
Nat Rev Neurosci. 2005 Mar;6(3):215-29
15738957
Acta Paediatr Taiwan. 2002 Nov-Dec;43(6):313-8
12632783
Nat Rev Drug Discov. 2006 Feb;5(2):160-70
16424917
Neuroscience. 1997 Dec;81(4):1111-22
9330372
J Neurosci. 1992 Mar;12(3):1040-62
1312131